<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03516266</url>
  </required_header>
  <id_info>
    <org_study_id>JS-1550</org_study_id>
    <nct_id>NCT03516266</nct_id>
  </id_info>
  <brief_title>A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female</brief_title>
  <official_title>A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Liuzhou Maternity and Child Healthcare Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qingdao Municipal Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhongshan City People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Affiliated Hospital of Soochow University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maternity and Child Health Hospital of Changsha</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henan Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huaian Maternal and Child Health Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hunan Provincial Maternal and Child Health Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fourth Hospital of Shijiazhuang City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shenzhen Luohu District Maternity And Child Healthcare Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Affiliated Hospital of Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hubei Shiyan People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changzhi Maternity &amp; Child Health Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maternal and Child Health Care Hospital of Xinjiang Uygur Autonomous Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Hospital of Hebei Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shen-Zhen City Maternity and Child Healthcare Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dalian Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maternity and Child Care Center of QinHuangDao City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The People's Hospital of Leshan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate the status of pelvic floor function of healthy female in&#xD;
      China, including premenopausal nullipara, premenopausal women with childbirth and&#xD;
      postmenopausal women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a cross-sectional survey. The normal physical examination population is divided into&#xD;
      three groups,including premenopausal nullipara, premenopausal women with childbirth and&#xD;
      postmenopausal women. The pelvic floor muscle function in three groups are evaluated. The&#xD;
      modified Oxford Grading Scale and Levator ani testing is used to quantify PFM strength&#xD;
      through vaginal palpation. Pelvic floor muscle strength ,endurance, repetition,vaginal&#xD;
      contraction pressure and the knack test are evaluated using a PHENIX USB 8 neuromuscular&#xD;
      stimulation therapy system (Company: Vivaltis-Electronic Concept Lignon Innovation,&#xD;
      Montpellier, France). In six different regions of China according to geographic region&#xD;
      (northwest, southwest, north, east, northeast, and central-south China) , 1 or more hospitals&#xD;
      in each area are selected as sub-centers, which needs to complete the evaluation of pelvic&#xD;
      floor muscle function of 360 cases in 3 groups totally.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">May 10, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>maximum vaginal contraction pressure</measure>
    <time_frame>1 day</time_frame>
    <description>it is measured by manometry, range(80-150cmH2O). The higher values represent better outcomes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pelvic floor muscle strength</measure>
    <time_frame>1 day</time_frame>
    <description>The modified Oxford Grading Scale is used to quantify PFM strength through vaginal palpation. range(0-5).The higher values represent better outcomes.&#xD;
through vaginal palpation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic floor muscle strength（repetition）</measure>
    <time_frame>1 day</time_frame>
    <description>Levator ani testing is used to quantify PFM strength. range(0-5). The higher values represent better outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic floor muscle contraction endurance</measure>
    <time_frame>1 day</time_frame>
    <description>muscle contractions maintained for 0 s are defined as grade 0, 1 s as grade I, 2 s as grade II, 3 s as grade III, 4 s as grade IV, and 5 s or longer as grade V. Normal muscles can maintain the contraction for 5 s. range(0-5s). The higher values represent better outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pelvic organ prolapse quantification</measure>
    <time_frame>1 day</time_frame>
    <description>POP-Q is measured when maximum valsalva. range(0-4). stage 0 represents normal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the knack test</measure>
    <time_frame>1 day</time_frame>
    <description>a voluntary PFM contraction before or during coughing. That the contraction could be performed represents normal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vaginal rest pressure</measure>
    <time_frame>1 day</time_frame>
    <description>measure when no vaginal contraction by manometry. range(25-50 cmH2O). the lower and the higher values represent abnormal outcomes.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">7920</enrollment>
  <condition>Pelvic Floor</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Volunteers are divided into three groups, and each clinical center requires at least 120&#xD;
        persons in each group.&#xD;
&#xD;
        Group A: Premenopausal women without history of abortion or delivery.&#xD;
&#xD;
        Group B: Premenopausal women with childbirth (including cesarean section or natural birth).&#xD;
&#xD;
        Group C:Postmenopausal women (except surgical menopause).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Group A：Premenopausal women without history of abortion or delivery&#xD;
&#xD;
          1. Having sex life and tolerable to vaginal examination&#xD;
&#xD;
          2. Premenopausal women without history of abortion over 16 weeks&#xD;
&#xD;
          3. Premenopausal women without history of childbirth&#xD;
&#xD;
          4. Planning to live locally for a long time&#xD;
&#xD;
        Group B：Premenopausal women with childbirth&#xD;
&#xD;
          1. Having sex life and tolerable to vaginal examination&#xD;
&#xD;
          2. Premenopausal women with childbirth (including cesarean section or natural birth).&#xD;
&#xD;
          3. Planning to live locally for a long time&#xD;
&#xD;
        Group C:Postmenopausal women (over a year, except surgical menopause)&#xD;
&#xD;
          1. Having sex life and tolerable to vaginal examination&#xD;
&#xD;
          2. Postmenopausal women&#xD;
&#xD;
          3. Planning to live locally for a long time&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Incontinence 4 weeks before enrollment&#xD;
&#xD;
          2. History of fecal incontinence&#xD;
&#xD;
          3. Prolapse beyond the level of the hymen&#xD;
&#xD;
          4. History of radical operation of pelvic cavity(cervical cancer,rectal cancer,bladder&#xD;
             cancer, ect）&#xD;
&#xD;
          5. History of pelvic radiotherapy&#xD;
&#xD;
          6. History of pelvic floor surgery&#xD;
&#xD;
          7. History of abortion over 16 weeks' pregnancy or in 1 year after delivery&#xD;
&#xD;
          8. Duration of pregnancy&#xD;
&#xD;
          9. Duration of lactation&#xD;
&#xD;
         10. History of hysterectomy&#xD;
&#xD;
         11. Latex allergy&#xD;
&#xD;
         12. Colpitis&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lan Zhu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhijing Sun, MD</last_name>
    <phone>13651314354</phone>
    <email>sunzhj2001@sina.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lan Zhu, MD</last_name>
    <email>zhu_julie@vip.sina.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences</name>
      <address>
        <city>Beijing</city>
        <state>Beiing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhijing Sun, MD</last_name>
      <phone>13651314354</phone>
      <email>sunzhj2001@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>April 13, 2018</study_first_submitted>
  <study_first_submitted_qc>May 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2018</study_first_posted>
  <last_update_submitted>May 10, 2018</last_update_submitted>
  <last_update_submitted_qc>May 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pelvic floor muscle strength</keyword>
  <keyword>Premenopausal nullipara</keyword>
  <keyword>Childbirth</keyword>
  <keyword>Postmenopausal</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

